These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 17724303)

  • 1. Longitudinal follow-up of "benign" multiple sclerosis at 20 years.
    Amato MP; De Stefano N
    Neurology; 2007 Aug; 69(9):938; author reply 938-9. PubMed ID: 17724303
    [No Abstract]   [Full Text] [Related]  

  • 2. Benign or not benign MS: a role for routine neuropsychological assessment?
    Benedict RH; Fazekas F
    Neurology; 2009 Aug; 73(7):494-5. PubMed ID: 19641172
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patients.
    Minneboo A; Uitdehaag BM; Ader HJ; Barkhof F; Polman CH; Castelijns JA
    Neurology; 2005 Jul; 65(1):56-61. PubMed ID: 16009885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamo-pituitary-adrenal axis activity predicts disease progression in multiple sclerosis.
    Gold SM; Raji A; Huitinga I; Wiedemann K; Schulz KH; Heesen C
    J Neuroimmunol; 2005 Aug; 165(1-2):186-91. PubMed ID: 15935481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of multiple sclerosis.
    Deshpande R; Kremenchutzky M; Rice GP
    Adv Neurol; 2006; 98():1-15. PubMed ID: 16400823
    [No Abstract]   [Full Text] [Related]  

  • 8. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
    Boster A; Hreha S; Berger JR; Bao F; Penmesta R; Tselis A; Endress C; Zak I; Perumal J; Caon C; Vazquez J; Tyler KL; Racke MK; Millis S; Khan O
    Arch Neurol; 2009 May; 66(5):593-9. PubMed ID: 19433659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of MRS and fMRI in multiple sclerosis.
    Tartaglia MC; Arnold DL
    Adv Neurol; 2006; 98():185-202. PubMed ID: 16400835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of modern magnetic resonance techniques to monitor disease evolution in multiple sclerosis.
    Filippi M; Rocca MA
    Adv Neurol; 2006; 98():167-83. PubMed ID: 16400834
    [No Abstract]   [Full Text] [Related]  

  • 11. The incomplete nature of multiple sclerosis relapse resolution.
    Lublin FD
    J Neurol Sci; 2007 May; 256 Suppl 1():S14-8. PubMed ID: 17337274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment in multiple sclerosis: a longitudinal study.
    Amato MP; Ponziani G; Amaducci L
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():465-8. PubMed ID: 10689495
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical features of relapsing remitting-multiple sclerosis. Prognostic factors].
    Fernández-Fernández O
    Rev Neurol; 2002 Dec 1-15; 35(11):1067-73. PubMed ID: 12497314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standards for sample composition and impairment classification in neuropsychological studies of multiple sclerosis.
    Benedict R
    Mult Scler; 2009 Jul; 15(7):777-8. PubMed ID: 19542261
    [No Abstract]   [Full Text] [Related]  

  • 15. Pediatric multiple sclerosis.
    Bigi S; Banwell B
    J Child Neurol; 2012 Nov; 27(11):1378-83. PubMed ID: 22914372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making the diagnosis of multiple sclerosis.
    Birnbaum G
    Adv Neurol; 2006; 98():111-24. PubMed ID: 16400830
    [No Abstract]   [Full Text] [Related]  

  • 17. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis.
    Rovira A; Swanton J; Tintoré M; Huerga E; Barkhof F; Filippi M; Frederiksen JL; Langkilde A; Miszkiel K; Polman C; Rovaris M; Sastre-Garriga J; Miller D; Montalban X
    Arch Neurol; 2009 May; 66(5):587-92. PubMed ID: 19433658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A composite score to predict short-term disease activity in patients with relapsing-remitting MS.
    Sormani MP; Rovaris M; Comi G; Filippi M
    Neurology; 2007 Sep; 69(12):1230-5. PubMed ID: 17875911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis.
    Hawker K; Frohman E
    Prim Care; 2004 Mar; 31(1):201-26. PubMed ID: 15110166
    [No Abstract]   [Full Text] [Related]  

  • 20. MRI as an outcome in multiple sclerosis clinical trials.
    Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
    Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.